Loss of heterozygosity at the RB-1 locus and pRB immunostaining in epithelial ovarian tumors: A molecular, immunohistochemical, and clinicopathologic study

International Journal of Gynecological Pathology

Volumn 20, Issue 4, 2001, Pages 335-340

  Gras, Esther ^a   Pons, Cristina ^a   Machin, Pilar ^a   Matias Guiu, Xavier ^a,b   Prat, Jaime ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

13q; Immunohistochemistry; Loss of heterozygosity; Mixed endometrioid serous carcinomas; Ovarian tumors; RB 1; Serous carcinomas; Sporadic ovarian cancers

Indexed keywords

RETINOBLASTOMA PROTEIN;

ALLELE; ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; CHROMOSOME 13Q; CONTROLLED STUDY; EPITHELIUM TUMOR; FEMALE; GENE LOCUS; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOLECULAR BIOLOGY; OVARY TUMOR; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0034790755     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004347-200110000-00004     Document Type: Article

References (32)

1. Retinoblastoma: A prototypic hereditary neoplasm
2. Mutation and cancer: Statistical study of retinoblastoma
3. Deletions of a DNA sequence in retinoblastomas and mesenchymal tumors: Organization of the sequence and its encoded protein
4. Role of the retinoblastoma protein in the pathogenesis of human cancer
5. Frequent loss of heterozygosity on chromosomes Xp and 13q in human ovarian cancer
6. Allele loss at the retinoblastoma locus in human ovarian cancer
7. Molecular analysis of the retinoblastoma gene in primary ovarian cancer cells
8. Evidence of functional RB protein in epithelial ovarian carcinomas despite loss of heterozygosity at the RB locus
9. Histological typing of ovarian tumours
10. Early de novo ovarian cancer and cancer developing in benign ovarian lesions
11. Current concepts in epithelial ovarian tumors: Does benign to malignant transformation occur?
12. K-ras activation occurs frequently in mucinous adenocarcinomas and rarely in other common epithelial tumors of the human ovary
13. K-ras mutations in mucinous ovarian tumors: A clinicopathologic and molecular study of 95 cases
14. Mutations in the b-catenin gene (CTNNBI) in endometrioid ovarian carcinomas
15. Genetic alterations on chromosome 17 distinguish different types of epithelial ovarian tumors
16. Loss of heterozygosity on chromosome 17q in epithelial ovarian tumors: Association with carcinomas with serous differentiation
17. Loss of heterozygosity on chromosome 13q, BRCA-2 mutations and promoter hypermethylation in sporadic ovarian tumors
18. Human retinoblastoma susceptibility gene: Cloning, identification, and sequence
19. Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product
20. The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle
21. Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cell differentiation
22. The E2F transcription factor is a cellular target for the RB protein
23. Reduced expression of retinoblastoma product (pRB) and high expression of p53 are associated with poor prognosis in ovarian cancer
24. Abnormal expression of the retinoblastoma gene in ovarian neoplasms and correlation to p53 and k-RAS mutations
25. Molecular pathology of ovarian carcinomas
26. Molecular genetic changes in human epithelial ovarian malignancies
27. Microsatellite instability in ovarian neoplasms
28. Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors
29. Microsatellite instability in endometrial carcinomas: Clinicopathologic correlations in a series of 42 cases
30. PTEN mutations in endometrial carcinomas: A molecular and clinicopathologic analysis of 38 cases
31. Promoter hypermethylation is a cause of BRCA1 inactivation in sporadic breast and ovarian tumors